Plain-English translation of NCT06967857 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing dexamfetamine sulfate—a stimulant medication—to see if it can help treat both ADHD and depression when they occur together in adults. The medication will be tested in two different forms: one you take twice daily and one you take once daily. The study will compare how well the medication works compared to a placebo (inactive pill).
Many adults with ADHD also experience depression, and current treatments don't always address both conditions well. This trial is exploring whether this medication might improve both focus and mood at the same time, offering a better treatment option for people dealing with both disorders.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to take either the study medication or a placebo in one of two forms. You would visit the research clinic multiple times so doctors can check how well the treatment is working and monitor your safety. Throughout the study, you'll continue taking your current antidepressant medication, but you'll stop any other ADHD treatments you may have been using.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Germany